Eric Andersen Biography and Net Worth

Director of Merrimack Pharmaceuticals

Eric D. Andersen has served as a member of our board of directors since September 2019. Mr. Andersen has been a managing member / portfolio manager at Western Standard, LLC, an investment firm, since June 2008. Prior to that, Mr. Andersen served as an analyst at Ivory Capital and JCK Partners, both investment firms, from 2006 to 2008 and 2004 to 2006, respectively; an associate in the private equity group at J.P. Morgan Partners, LLC from 2002 to 2004; and an analyst, mergers and acquisitions, at The Blackstone Group, an investment firm, from 2000 to 2002. Mr. Andersen holds a B.A. from Dartmouth College and is a CFA Charterholder. We believe Mr. Andersen is qualified to serve on our board of directors due to his investment management experience and strong financial and business acumen.

What is Eric Andersen's net worth?: The estimated net worth of Eric Andersen is at least $8.07 million as of December 26th, 2023. Mr. Andersen owns 533,151 shares of Merrimack Pharmaceuticals stock worth more than $8,066,575 as of November 21st. This net worth approximation does not reflect any other assets that Mr. Andersen may own. Learn More about Eric Andersen's net worth.
How do I contact Eric Andersen?: The corporate mailing address for Mr. Andersen and other Merrimack Pharmaceuticals executives is ONE BROADWAY 14TH FLOOR, CAMBRIDGE MA, 02142. Merrimack Pharmaceuticals can also be reached via phone at 617-720-8606 and via email at [email protected]. Learn More on Eric Andersen's contact information.
Has Eric Andersen been buying or selling shares of Merrimack Pharmaceuticals?: Eric Andersen has not been actively trading shares of Merrimack Pharmaceuticals during the past quarter. Most recently, on Thursday, December 28th, Eric Andersen bought 857 shares of Merrimack Pharmaceuticals stock. The stock was acquired at an average cost of $13.35 per share, with a total value of $11,440.95. Following the completion of the transaction, the director now directly owns 534,008 shares of the company's stock, valued at $7,129,006.80. Learn More on Eric Andersen's trading history.
Who are Merrimack Pharmaceuticals' active insiders?: Merrimack Pharmaceuticals' insider roster includes Eric Andersen (Director), Gary Crocker (Insider), Noah Levy (Director), and Ulrik Nielsen (Director). Learn More on Merrimack Pharmaceuticals' active insiders.
Are insiders buying or selling shares of Merrimack Pharmaceuticals?: In the last twelve months, Merrimack Pharmaceuticals insiders bought shares 3 times. They purchased a total of 150,600 shares worth more than $1,950,246.40. The most recent insider tranaction occured on December, 28th when Director Eric Andersen bought 857 shares worth more than $11,440.95. Insiders at Merrimack Pharmaceuticals own 30.6% of the company. Learn More about insider trades at Merrimack Pharmaceuticals.
Information on this page was last updated on 12/28/2023.

Eric Andersen Insider Trading History at Merrimack Pharmaceuticals

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/28/2023	Buy	857	$13.35	$11,440.95	534,008
12/26/2023	Buy	48,693	$13.15	$640,312.95	533,151
12/7/2023	Buy	101,050	$12.85	$1,298,492.50	1,735,600
11/17/2023	Buy	300	$12.50	$3,750.00	1,659,216
11/14/2023	Buy	50,170	$12.50	$627,125.00	1,658,981
8/7/2023	Buy	134,493	$12.00	$1,613,916.00	1,496,680
3/21/2023	Buy	160,590	$11.52	$1,849,996.80	1,412,044
1/30/2023	Buy	24,708	$11.36	$280,682.88	1,282,853
1/27/2023	Buy	21,875	$11.40	$249,375.00	1,263,103
4/14/2021	Buy	47,300	$6.63	$313,599.00
4/12/2021	Buy	23,629	$6.06	$143,191.74
8/11/2020	Buy	14,030	$3.45	$48,403.50
7/22/2020	Buy	177,274	$3.11	$551,322.14
4/6/2020	Buy	16,793	$3.46	$58,103.78

Eric Andersen Buying and Selling Activity at Merrimack Pharmaceuticals

Merrimack Pharmaceuticals Company Overview

Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company in the United States. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

Today's Range

Now: $15.13

$15.13

50 Day Range

MA: $14.82

$14.65

$15.13

2 Week Range

Now: $15.13

$11.53

$15.89

Volume

N/A

Average Volume

396,929 shs

Market Capitalization

$223.77 million

P/E Ratio

1.09

Dividend Yield

N/A

Beta

1.45

Trump’s Sending THIS Crypto Higher on Purpose

From Crypto 101 Media | Ad

Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin…

YES, I WANT THE #1 CRYPTO NOW